Table 1 Patient and disease characteristics of PART2-cohort
Age (years) | 55.7 (13.2) | |
Female—N (%) | 126 (51.2%) | |
PASDASa | Mean | 3.04 (1.40) |
LDA (≤ 3.2)–N (%) | 87 (53.7%) | |
Remission (≤ 1.9)–N(%) | 37 (22.7%) | |
DAS28-CRP | Mean | 2.17 (0.93) |
LDA (2.9)–N (%) | 183 (79.9%) | |
Remission (2.4)–N (%) | 159 (69.4%) | |
SJC68—N (%) | 0 | 169 (68.7%) |
1–4 | 60 (24.4%) | |
5 or more | 12 (5.3%) | |
TJC68–N (%) | 0 | 117 (47.6%) |
1–4 | 79 (32.1%) | |
5 or more | 45 (18.3%) | |
LEI–N (%) | 0 | 185 (75.2%) |
1 | 22 (8.9%) | |
2 or more | 22 (8.9%) | |
Active dactylitis–N (%) | 5 (2.0%) | |
Global VAS | Physician | 14.4 (15.3) |
Patient | 31.6 (23.5) | |
CRP | 3.76 (8.6) | |
SF12 | PCSb | 41.6 (10.2) |
MCSb | 49.1 (10.6) | |
HAQc | 0.63 (0.6) | |
DMARD use–N (%) | None | 36 (14.6%) |
csDMARD | 116 (47.5%) | |
b/tsDMARD | 94 (38.2%) |